Adalimumab-afzb Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Adalimumab-afzb Injection (injection) from Pfizer Inc. with status No longer listed by FDA. The shortage was first posted on Oct 9, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Pfizer Inc.
- Package NDC
- 0025-0325-01
- Dosage Form
- Injection
- Presentation
- Abrilada, Injection, Kit (NDC 0025-0325-01)
- Initial Posting
- Oct 9, 2025